Risk factor
Good trading liquidity
Profitability factor
Very strong margins and returns
About
China Resources Jiangzhong Pharmaceutical Co.,Ltd engages in the manufacture of pharmaceutical products in China. The company offers OTC products, including stomach-strengthening and digestion-promoting tablets, lactobacillus tablets, triple live bifidobacterium enteric-coated capsules, compound fresh bamboo juice liquid, compound coral lozenges, multivitamin tablets, Fritillaria and loquat capsules, bezoar and snake gallbladder Fritillaria liquid, and compound gold melon seed. It also provides health consumer and other products, such as nourishing, rehabilitation nutrition, gastrointestinal health, and liver health products. In addition, the company offers prescription drugs comprising traditional Chinese medicine products, which includes Shenbao capsules, Paishi granules, Huangba Shengmai drink, Bazhen Yimu capsules, Zhenju Jiangya tablets, Shuangju granules, Zhikang tablets, Shuxiong granules, etc.; chemical medicine products, such as lumbrokinase enteric-coated capsules, Rabelagat sodium enteric-coated tablets, chloroprocaine hydrochloride, etc.; and medicinal materials which includes stir-fried Chinese jujube seeds, French pinellia, and vinegar-soaked northern bupleurum. The company was formerly known as Jiang Zhong Pharmaceutical Co.,Ltd and changed its name to China Resources Jiangzhong Pharmaceutical Co.,Ltd in January 2025. China Resources Jiangzhong Pharmaceutical Co.,Ltd was founded in 1996 and is headquartered in Nanchang, China.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITDA, re